文献速递瓣膜外科

对合长度可预测退行性二尖瓣修复术后早期与中期的耐久性

Coaptation length predicts early- and intermediate-term durability following degenerative mitral repair.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究在单中心比较386例退行性二尖瓣修复患者,术后对合长度>11 mm组(230例)与≤11 mm组(156例)相比,长对合组复发二尖瓣反流中度及以上免除率显著更高(IPTW校正平均复发时间差31个月,95%CI 9-53,P=0.006),但中期生存无差异。结论认为较长的对合长度似乎与改善的中期修复耐久性相关。

要点

  • 术后对合长度>11 mm组复发二尖瓣反流中度及以上免除率显著高于≤11 mm组(IPTW校正平均时间差31个月,95%CI 9-53,P=0.006)。
  • 两组中期生存无差异(IPTW校正平均死亡时间差9.5个月,95%CI -27至46,P=0.61)。
  • 长对合组更多采用人工腱索植入(89% vs 65%,P<0.001),更少行瓣叶切除(11% vs 29%,P<0.001)。

核心结论

  • 较长的对合长度似乎与退行性二尖瓣修复术后改善的中期耐久性相关。

研究设计与样本

  • 单中心连续纳入2008年5月至2021年2月间386例因退行性二尖瓣反流行二尖瓣修复的患者。
  • 按术后对合长度>11 mm(长对合组,n=230)与≤11 mm(短对合组,n=156)分组比较,并进行倾向性评分逆概率加权(IPTW)分析。
  • 临床随访中位时间41个月,全队列随访完整。

主要发现

  • 长对合组人工腱索植入比例高于短对合组(89% vs 65%,P<0.001),瓣叶切除比例低于短对合组(11% vs 29%,P<0.001)。
  • 总体院内/30天死亡3例(1%),二尖瓣再干预4例(1%)。
  • 复发二尖瓣反流免除率1年为98%,5年为94%。
  • 长对合组复发二尖瓣反流中度及以上免除率显著更高(IPTW校正平均复发时间差31个月,95%CI 9-53,P=0.006)。
  • 两组中期生存无差异(IPTW校正平均死亡时间差9.5个月,95%CI -27至46,P=0.61)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The impact of coaptation length on recurrent mitral regurgitation following degenerative mitral repair is not fully understood. METHODS: Between May 2008 and February 2021, 386 consecutive patients underwent mitral repair for degenerative mitral regurgitation at a single centre. We compared patients with a post-repair coaptation length >11 mm (long-coaptation group, n = 230) and ≤11 mm (short-coaptation group, n = 156). The coaptation length cutoff was selected based on published postoperative transesophageal echocardiographic measurement of mitral repair patients and healthy controls. Propensity score with inverse probability of treatment weighting (IPTW) analyses were performed. The median duration of clinical follow-up was 41 months and follow-up was complete in the entire cohort. RESULTS: The long-coaptation patients underwent more neochord implantation (89% vs 65%, P < 0.001) and less leaflet resection (11% vs 29%, P < 0.001). Overall in-hospital/30-day mortality and mitral reintervention occurred in 3 (1%) and 4 (1%) patients, respectively, and freedom from recurrent mitral regurgitation was 98% at 1 year and 94% at 5 years. Freedom from recurrent mitral regurgitation moderate or greater was significantly higher in the long-coaptation patients (IPTW-adjusted difference in average time to recurrent mitral regurgitation: 31 months, 95% confidence interval 9-53, P = 0.006). However, there was no difference in intermediate-term survival between both groups (IPTW-adjusted difference in average time to death: 9.5 months, 95% confidence interval -27 to 46, P = 0.61). Stratified analysis and pairwise comparison of different coaptation intervals also appeared to support the protective effect of longer coaptation on repair durability. CONCLUSIONS: Longer coaptation length appears to be associated with improved intermediate-term durability after mitral repair.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Hage F, Hage A, Malik MI, et al. Coaptation length predicts early- and intermediate-term durability following degenerative mitral repair. Eur J Cardiothorac Surg. 2022. PMID: 36125068. doi:10.1093/ejcts/ezac194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。